{"certainAgreement":{"otherDetails":"After study conclusion and without prior written approval from Immunomedics and Gilead sciences, investigators in this study may communicate, orally present/publish in scientific journals/other media only after following conditions have been met:\n\n* The results of the study in their entirety have been publicly disclosed by or with the consent of Immunomedics and Gilead sciences in an abstract, manuscript/presentation form; or\n* The study has been completed at all study sites for at least 2 years","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"GileadClinicalTrials@gilead.com","organization":"Gilead Sciences","phone":"1-833-445-3230 (GILEAD-0)","title":"Gilead Clinical Study Information Center"}}